Superovulation and embryo quality in beef cows using PMSG and a monoclonal anti-PMSG

The long half-life of pregnant mare serum gonadotrophin (PMSG) reduces its application in the superovulation of cattle; thus, a monoclonal antibody to PMSG (anti-PMSG) was administered at the onset of estrus to increase the number of transferable embryos. Angus, Hereford and Angus x Hereford cows (n = 149) 3 to 9 yr old were assigned randomly to one of three dosages of PMSG (1500, 3000 or 6000 IU) with or without an equivalent dosage of anti-PMSG. Embryos were collected nonsurgically on Day 8 (estrus = Day 0), and all cows were ovariectomized on Day 9. The percentage of cows exhibiting estrus and ovulating decreased (P<0.05) with an increasing dosage of PMSG (82, 76 and 44% for 1500, 3000 and 6000 IU, respectively). Ovarian and total corpora lutea (CL) weight increased (P<0.001) linearly as PMSG dosage increased, but were reduced (P<0.001) curvilinearly by anti-PMSG, resulting in a PMSG by anti-PMSG interaction (P<0.001); the interaction was also significant (P<0.05) for ovulation rate (14.0 vs 14.3, 21.5 vs 24.4 and 29.2 vs 6.6 CL for 1500, 3000 and 6000 IU PMSG, without vs with anti-PMSG, respectively). Anti-PMSG increased (P<0.001) the number of small ovarian follicles (1 to 3 mm diameter) and decreased (P<0.001) the number of large follicles (>10 mm) at ovariectomy; the number of large follicles increased (P<0.001) with PMSG dosage. The number of total and transferable embryos recovered did not differ among PMSG and anti-PMSG dosages; however, the percentage of transferable embryos decreased (P<0.01) with increasing PMSG dosage. In general, neither PMSG dosage nor anti-PMSG influenced embryo quality.     

A large-scale program in laparoscopic intrauterine insemination with frozen-thawed semen in Australian Merino sheep in Argentine Patagonia

This report shows the results of a large-scale laparoscopic intrauterine insemination program on a flock of Australian Merino sheep in Argentine Patagonia. The study was carried out on a total of 1824 ewes (3-to-7-yr-old) and 480 ewe hoggets (19-20 months old) on 2 farms in the southeastern region of Santa Cruz Province, in April and May 1996. The animals, divided into 15 groups, were synchronized with vaginal sponges containing 60 mg medroxyprogesterone acetate for 14 d and injected with 200 IU PMSG upon sponge removal. Estrus was screened every 12 h by means of vasectomized marker rams. The animals were inseminated laparoscopically by the intrauterine route using 2 schemes: 1) at a fixed time (12 h) after estrus detection, or 2) at a fixed time (60 h) after sponge removal irrespective of estrus. Pregnancy was determined at 30 d by transrectal ultrasound imaging. The results showed that 1) the onset of estrus occurs most often between 24 and 48 h after sponge removal, 2) ewe hoggets undergo estrus significantly earlier than sexually mature ewes, 3) in those animals showing estrus, there appears to be no relationship between fertility (as assessed by pregnancy outcome) and time of estrus, 4) there is a significant association between the percentage of estrus occurrence and pregnancy rate, 5) fertility is significantly higher in ewes than in hoggets, 6) for practical purposes insemination at a fixed time after the onset of estrus has no advantage over that of to insemination at a fixed time after sponge removal. It is concluded that large-scale laparoscopic intrauterine insemination can be successfully applied in Australian Merino ewes and ewe hoggets in low-productivity areas such as that of Argentine Patagonia and that estrus detection is unnecessary when insemination is performed at 60 h after sponge removal.     

Cervical dilation, conception rate, and concentrations of progesterone and estradiol-17B in postpartum ewes treated with porcine relaxin

Experiments were conducted to determine the effects of porcine relaxin (pRLX) on cervical dilation and conception rates in postpartum ewes. In Experiment 1, ewes received medroxyprogesterone acetate (MAP) sponge on day 16 (day 0 = lambing) and 750 IU pregnant mare serum gonadotropin (PMSG) at sponge removal on day 30. Control ewes received saline and relaxin-treated (RLX) ewes received 0.5 mg pRLX (>/= 3000 U/mg) i.m. at 24 h and 1.0 mg pRLX at 36 h after PMSG. All ewes were inseminated (Al) at 55 h after PMSG with 0.4 ml fresh semen. The proportion of RLX treated ewes (6 6 ) in which the cervix was penetrated was greater (P < 0.05) than in Control ewes (0 5 ). However, ova recovery rate was lower (P < 0.05) for RLX ewes (1 6 ) than for control ewes (5 5 ). In Experiment 2, ewes between Days 90 to 120 post partum received MAP sponges for a period of 8 d and 750 IU PMSG at sponge removal. Control ewes (n = 9) received saline; RLX-1 ewes (n = 8) received 0.5 mg pRLX at 24 h and an additional 0.5 mg pRLX at 36 h after PMSG; and RLX-1.5 ewes (n = 9) received 0.5 mg pRLX at 24 h and an additional 1.0 mg pRLX at 36 h after PMSG. Ewes were mated to rams at estrus, and cervical dilation was checked at 55 h after PMSG. The cervix could not be penetrated in any of the ewes. Conception rates on Day 26 were 66, 56 and 63% for control, RLX-1 and RLX-1.5 groups, respectively. These results demonstrate that the effect of relaxin on cervical dilation and conception rate is dependent upon the postpartum stage of the ewes.     

Superovulatory response of Chios sheep to PMSG during spring and autumn

To study the superovulatory response of Chios sheep to pregnant mares' serum gonadotrophin (PMSG), two experiments were carried out; one in spring and one in autumn. Four doses of PMSG (1500 IU, Group 1; 1000 IU, Group 2; 750 IU, Group 3; 500 IU, Group 4; controls, Group 5) were tested on 46 ewes. Oestrus was synchronised by means of MAP intravaginal sponges and PMSG was injected i.m. at the time of sponge withdrawal. When in oestrus, ewes were naturally mated. On Day 7 after sponge removal, mid-ventral laparotomy was performed and the uterine horns and/or oviducts were flushed with 20–40 ml Dulbecco's phosphate-buffered saline supplemented with 15% foetal bovine serum (FBS). The embryos were examined under a dissecting microscope and were evaluated according to morphological criteria.The interval from sponge removal to the onset of oestrus was significantly (P < 0.001) shorter in autumn than in spring in all groups. No significant differences regarding superovulatory response, collection and fertilisation rate or numbers of ova and embryos collected were found between spring and autumn. The clinical signs of oestrus started earlier (P < 0.001) in all PMSG treated animals than in the controls, both in spring and in autumn. The highest ovulation rate was recorded in Group 2 (5.9 ± 1.0), followed by Groups 1 (5.0±0.9), 3 (3.9±0.5), 4 (26±0.4) and 5 (1.3±0.1). The increase observed in total ovarian response (corpora lutea + large anovulated follicles) parallelled the increase of PMSG dose (10.7 ± 1.6, 7.7 ± 0.9, 4.5 ± 0.6, 3.4 ± 0.5 and 1.8 ± 0.2 for Groups 1, 2, 3, 4 and 5, respectively). The highest mean number of ova was collected from Group 3 (3.4±0.5), followed by Groups 2 (2.6 ± 0.4), 4 (2.2 ± 0.3), 1 (1.6 ± 0.5) and 5 (1.1 ± 0.1). The higher doses of PMSG (1500 and 1000 IU) significantly increased the mean number of anovulated follicles and significantly decreased recovery rate. Mean number of high viability embryos collected per ewe treated (0.9 ± 0.6, 1.5 ± 0.4, 2.2 ± 0.5, 1.5 ± 0.4, 0.9 ± 0.1 for Groups 1, 2, 3, 4 and 5, respectively) was not improved by PMSG dose.It is concluded that Chios sheep can be superovulated in autumn and in spring with similar results. Clinical signs of oestrus are initiated earlier in autumn than in spring. PMSG treatment shortens the interval from sponge removal to the onset of oestrus. Although PMSG does not seem to be the most suitable hormone for the induction of superovulation in Chios sheep, a dose of 750–1000 IU PMSG gives satisfactory results; higher doses are associated with side effects in a significant number of animals (many anovulated follicles, low recovery rate).     

Effect of injection time of anti-PMSG antiserum on ovulation rate and quality of embryos in superovulated cows

Eighteen cows were superovulated by injecting 3000 IU of PMSG during the luteal phase, followed 48h later with an injection of Estrumate. They were then placed in a control group or were given anti-PMSG antiserum at either 12h or 24h after the onset of oestrus. Sixteen of these animals were used for the same experiment five months later. The results were pooled because they were not significantly different between the two treatment periods. The timing of the injection of anti-PMSG antiserum, either 12h (11 cows) or 24h (12 cows) after the onset of oestrus, did not significantly affect the ovulation rate, the number of embryos collected or the number of good embryos. The antiserum significantly increased the number of good embryos but did not affect the ovulation rate or embryo recovery. It is concluded that even with a moderate dose of PMSG, the use of anti-PMSG at 12h or 24h after the beginning of oestrus improves the quality of embryos. The mean number of embryos to be transferred (5.5) is in the range of those obtained after the FSH treatments, but the procedure required only three injections compared with nine for the FSH treatment.     

Effects of time of PMSG and fixed-time GnRH injections on estrus incidence and fertility in physiologically different ewes pre-treated with progestogen-impregnated vaginal sponge during the nonbreeding season

A 2 × 2 factorial study for hormonal treatment was designed in 85 seasonally anestrous ewes with physiologically different status (nonparous, dry, and postpartum). All ewes were pre-treated with 60 mg of 6-methyl-17-acetoxy-progesterone (MAP) vaginal sponge for nine days and divided into four groups: Group I (22 ewes) — an i. m. injection of 600 i.u. pregnant mare's serum gonadotropin (PMSG) at the sponge removal (Day 0) and a single i.m. injection of 100 ug synthetic gonadotropin releasing hormone (GnRH) at 36 h after the sponge removal; Group II (21 ewes) — a PMSG injection at Day 0 and a saline injection at 36 h after the sponge removal; Group III (21 ewes) — a PMSG injection two days before the sponge removal and the GnRH injection at 24 h after the sponge removal; and Group IV (21 ewes) — a PMSG injection at Day -2 and a saline injection at 24 h after the sponge removal. The treated ewes were allowed to mate once with rams for five days after treatment. Estrus incidence and lambing rates were low (69.4% and 27.1%, respectively), probably due to the mating system and poor body condition of ewes used in the study. No effect of PMSG injection two days before with-drawal of MAP sponge and the fixed-time GnRH injection were observed in estrus incidence, fertility, and prolificacy. The present study indicates that the physiological status of ewes combined with management systems including feeding and mating would be important for out-of-season breeding with hormonal treatment.     

Administration of 6-methoxybenzoxazolinone (MBOA) does not augment ovulatory responses in St. Croix White ewes superovulated with PMSG

The objective of this investigation was to examine the effects of 6-methoxy-benzoxazolinone (MBOA), a plant compound that resembles melatonin and alters ovarian function in rodents, in combination with PMSG on superovulatory responses in the cycling ewe. In Experiment I, St. Croix White ewes (n = 44) were synchronized (intra-vaginal progestin sponge) for 14days followed by hCG (750 IU) at 1 day after sponge removal (day 0). Ewes were assigned to one of six treatments administered on day -1: Control (no PMSG or MBOA; n = 7); PMSG (1000 IU i.m.; n = 7); Low MBOA (0.43 mg/kg i.m.; n = 7); High MBOA (1.15 mg/kg i.m.; n = 7); Low MBOA + PMSG (n = 8); High MBOA + PMSG (n = 8). In Experiment II, St. Croix White ewes (n = 24) were synchronized (progestin CIDR) for 14 days followed by hCG on day 1 after CIDR removal (day 0). Ewes were assigned to one of three treatments administered on day -1: Control (n = 8); PMSG (n = 8); Low MBOA+PMSG (n = 8). Laparoscopy was performed on day 9 to assess numbers of corpora lutea (CL) and visible follicles on each ovary. Blood samples were collected on day -13, -1, 0, 1, and days 6 or 7-12 for analysis of serum progesterone (P4) by RIA. Treatment groups receiving PMSG (alone or with MBOA) exhibited greater (P < 0.05) serum concentrations of P4 post-synchrony than Control and MBOA-only groups. Ovulation rate was lower (P < 0.05) for Control and MBOA-only treated ewes than ewes receiving PMSG. Ovulation rate in ewes treated with MBOA alone was similar (P > 0.10) to Controls, and PMSG treatment alone did not differ (P > 0.10) from MBOA + PMSG treatment. Ewes treated with PMSG alone did not differ (P > 0.10) in follicle number from High MBOA + PMSG treated ewes, however, Low MBOA + PMSG treated ewes had greater numbers of follicles at day 9 (P < 0.05) than the PMSG or High MBOA + PMSG groups in Experiment I; although, this was not replicated in Experiment II with numbers of follicles in the Low MBOA + PMSG group being similar (P > 0.10) to PMSG alone. In summary, the addition of MBOA in combination with PMSG as part of a synchronization-superovuation protocol in the ewe did not increase ovulation rate.     

Effects of progestagen treatments and PMSG on the induction of the preovulatory LH discharge in ewes

The characteristics of the induced preovulatory LH discharge were compared in ewes after treatment for 12 days with intravaginal sponge pessaries impregnated with 40 mg Fluorogestone Acetate or with subcutaneous ear implants containing varying quantities of Norgestomet. In Experiment 1, ewes were treated with intravaginal sponges or implants alone. In Experiment 2, ewes received similar treatments and 500 IU pregnant mares' serum gonadotropin (PMSG) i.m. at the time of sponge or implant removal. The duration of the LH discharge and an estimate of the total LH discharged were similar among treatment groups within the same experiment. Overall, the onset of LH release occurred approximately 8 h earlier in ewes treated with implants, whether or not PMSG was used. Use of PMSG, in conjunction with implant or sponge treatments, shortened the mean interval from sponge or implant removal to the onset of LH release from 41 to 28 h and doubled the estimated total LH discharged, compared with treatments using sponges or implants alone.     

The effects of different PMSG doses on estrus behavior and pregnancy rate in Angora goats

Artificial insemination protocols depend on efficient behavioral estrus detection and insemination time in Angora goat. Therefore, we aim to determine the accuracy of an estrus scoring system in Angora goats with different PMSG doses during the breeding season. Does (n: 260) were randomly divided into three groups: group-1 (n: 93), group-2 (n: 85) and group-3 (n: 82). All animals received an intravaginal sponge on day 0 for 11 days, and on the day of sponge insertion 150 μg prostaglandin F2Α was administered. Pregnant mare’s serum gonadotropin was injected 300, 400 and 500 IU intramuscularly 24 h before sponge removal to groups 1, 2 and 3, respectively. Estrus signs were detected with a teaser buck, 24 h after sponge removal according to a visual scoring system. Artificial insemination was performed with 0.25 ml fresh diluted semen at 43 to 45 h after sponge removal. Differences were observed within PMSG groups in terms of standing, tail wagging, courtship behavior, vaginal discharge and vaginal hyperemia (P<0.001). Nevertheless, the most accurate indicators of estrus that result in pregnancy were tail wagging and courtship behavior followed by standing estrus (P<0.05). According to the results obtained, 300 IU PMSG dose is sufficient, both to inseminate at a fixed time (43 to 45 h after sponge removal) and to record the estrus behavior by teaser male 24 h after sponge removal. Higher PMSG doses (400 to 500 IU) altered the timing of ovulation; specifically, 500 IU dose shortened the duration of estrus behaviors. In conclusion, even though the different doses of PMSG displayed similar effects on estrus synchronization and pregnancy rates, we concluded that tail wagging, courtship behavior and standing heat are the most reliable estrus signs for artificial insemination in Angora goat.     

Superovulatory response and quality of embryos recovered from anestrus ewes after a single injection of porcine FSH dissolved in polyvinylpyrrolidone

The effects of a single injection of porcine FSH (pFSH) administered in long acting vehicle on the superovulatory response of milk (Sarda breed) sheep were determined during the anestrous season. The sheep (n=42), synchronized with intravaginal sponges (40 mg fluorogestone acetate -FGA- for 14 d) were submitted 24 h before sponge removal to three different superovulatory treatments. Group 1 (n=16) was treated with a single intramuscular (im) injection of 16 mg of pFHS dissolved in 30 % polyvinylpyrrolidone (PVP); Group 2 (n=12) was injected im with 6, 5, 3 and 2 mg of pFSH every 12 h over 2 d; Group 3 (n=14) was given 800 IU of PMSG and 12 mg of pFSH. All sheep were mated with a fertile ram. Embryos were recovered surgically at Day 7 of sponge removal and graded for the quality according to their morphology. The percentage of good quality embryos recovered was 84% in Group 1, 68% in Group 2 and 77% in Group 3. Data for the onset of estrus, number of corpora lutea (CL), number of unovulated follicles, embryo recovery rate, embryo quality and fertilization rate were recorded for the 3 groups. The onset of estrus, number of CL, number of unovulated follicles, fertilization rate and number of good quality embryos did not differ significantly among the 3 groups. The embryo recovery rate was significantly lower in the group treated with PMSG-FSH (Group 3) than in the 2 other groups. It is concluded that during the anestrous season a single injection im of pFSH results on average in a superovulatory response as good as the more traditional treatments like multiple injections of pFSH and PMSG-pFSH combined.     

Induction of estrus with intramuscular injections of GnRH or PMSG in lactating goats (Capra hircus ) primed with a progestagen during seasonal anestrus

In Experiment 1, goats in seasonal anestrus (n=154) were treated with sponges impregnated with 1 of 2 types of progestagen (MAP or FGA) followed by PMSG (400 IU im) 48 h before sponge removal. The type of progestagen used had no effect on kidding, abortion, pseudogestation, multiple births, stillbirths, number of live births per doe or gestation length. In Experiment 2, lactating goats (n=24) in seasonal anestrus were treated with progestagen sponges (MAP). At sponge removal they received one of the following treatments: 1 injection of PMSG (400 IU im), 1 injection of GnRH (125 mug im; GnRH-1), or 2 injections of GnRH (125 mug/injection im; GnRH-2) at a 48 h interval. Serum samples were taken at 6-h intervals for 96 h, starting 12 h after sponge removal. Heterologous radioimmunoassays were validated for the measurements of goat FSH, LH, E(2) and P(4). The onset of estrus (P=0.004), mean doe receptivity (P=0.0006), maximum preovulatory E(2) concentrations (P=0.0001) and LH peak concentrations (P=0.08) occurred significantly later for GnRH-1 and GnRH-2 than for PMSG treatment. The PMSG treatment induced a preovulatory LH peak in a greater number of goats (P=0.05) and gave a higher gestation rate than GnRH-1 and GnRH-2 treatments (57 vs 0 vs 12%; P=0.03). It is likely that the GnRH treatments administered did not reactivate the hypothalamo-pituitary-gonadal axis. Thus, intramuscular injections of GnRH in lactating goats primed with a progestagen were not as effective in regulating reproductive performance during seasonal anestrus as were injections of PMSG.     

Estrus, ovulation and conception following timed insemination in Romney ewes treated with progestagen and gonadotropins.

The estrus — ovulation time relationships was examined in Romney ewes treated with progestogen (intravaginal sponge) and gonadotropins (PMSG + HCG or PMSG alone) prior to (January) and during (April) the breeding season. The conception rate of ewes inseminated at predetermined times after treatment was also investigated.Ewes exhibited estrus sooner after sponge removal in April than in January (34.9 v 38.9 hrs, P < 0.001). The interval from sponge removal to ovulation was also shorter in April than in January (56.3 – 62.1 hrs, P < 0.01). There were no significant differences between treatments or season on the mean interval from estrus to ovulation. Types of gonadotropin treatment had no effect on the estrus — ovulation time relationships. There were no significant effects of season, hormone treatment or time of insemination on lambing rate.     

Repeated endoscopic ovum pick-up in sheep

Endoscopy is an effective and minimally invasive technique which offers the possibility of repeated ovum pick-up (OPU). In this study 4 different treatment programs (Groups A, B, C and D) for repeated endoscopic OPU in sheep were investigated. The number of follicles and oocytes, quality of cumulus-oocyte-complexes (COCs), and detectable effects on fertility of the donor ewes were compared. Each group consisted of 5 East Friesian Milksheep. In Group A, follicles were punctured twice a week, in Group B once a week, and in Group C once a week followed by administration of 1500 IU PMSG 48 h prior to OPU. In Group D follicles were punctured and the sheep stimulated with 1500 IU PMSG 48 h prior to OPU once every 2 weeks. The PMSG-stimulated sheep received anti-PMSG immediately after OPU. Over a period of 10 weeks 216 OPU-sessions were performed. A total of 1978 follicles was punctured, and 1098 oocytes were recovered, for a collection rate of 55.5%. In the Groups A, B, C and D an average of 6.8, 8.6, 12.2 and 14.9 follicles per animal and session was aspirated, and an average of 3.8, 4.9, 7.0 and 7.6 COCs per animal per session was recovered, respectively. No significant differences between groups were observed in the collection rates (51.1 to 57.1%) or in the quality of the COCs, and 65 to 70% of the COCs were suitable for in vitro production of ovine embryos. Seven sheep developed small adhesions between the ovary and infundibulum. After the study 15 ewes became pregnant following natural mating with the same fertile ram (5 from Group A, 1 from Group B, 4 from Group C and 5 from Group D). In conclusion, OPU once a week in PMSG/anti-PMSG treated ewes was found to be the most effective treatment program for oocyte collection.     

A histological study of corpora lutea from superovulated beef heifers

There is great variability between animals in the number of viable embryos produced following different superovulation regimens. It is not clear if all the follicles that ovulate produce healthy oocytes and form normal corpora lutea (CL) following superovulation. The objective of this study was to assess and compare CL from heifers undergoing three superovulatory regimes with CL from unstimulated heifers on the basis of morphology and morphometric analysis of luteal cells.Beef heifers were superovulated using either: (a) 24 mg porcine follicle stimulating hormone (pFSH) given twice daily over a 4 day period in decreasing doses commencing on day 10 of the oestrous cycle; (b) a single injection of 2000 IU pregnant mare serum gonadotrophin (PMSG) given on day 10 of the cycle; (c) as in (b) but followed by 2000 IU anti-PMSG (IgG to neutralise endogenous PMSG) at the time of the first insemination which was 12–18 h after the onset of oestrus (n = 33 per treatment). Luteolysis was induced 48 h after initial gonadotrophin administration and CL were collected on day 7 of the subsequent cycle and from ten unstimulated heifers (controls) at the same stage of the oestrous cycle. CL morphology was studied at light and electron microscopy levels. Morphometric analysis was performed on luteal cells. Subcellular morphology was similar in heifers from all groups. However, CL from superovulated heifers had more connective tissue than CL from control heifers; the connective tissue content of CL in the anti-PMSG-treated group was particularly marked. Both large and small luteal cells in the heifers receiving anti-PMSG had significantly smaller (P < 0.001) area and sphere volume than similar cells from CL of heifers in the other groups.     

Effect of the method of estrus synchronization and PMSG dosage on estrus and twinning in Ethiopian Menze sheep

Mature, cyclic Ethiopian Menze ewes (n = 72) were used in this study. They were divided into 6 equal groups in a 2x3 factorial experimental design. Estrus and ovulation were synchronized in all ewes using either 2 dosages of prostaglandin F2 alpha 12 days apart (n = 36) or intravaginal progestogen sponges for an equal length of time (n = 36). At sponge removal or at the second prostaglandin injection, equal groups of ewes were injected with either 0, 200, or 300 IU of PMSG. Prostaglandin-synchronized ewes exhibit estrus significantly earlier (P = 0.025) than the progestogen-synchrcnized group. Although PMSG treatment increased twinning rates and therefore total number of lambs born, the differences between groups did not reach significant levels (P>0.10).     

Simplified superovulatory treatments in Corriedale ewes

Two experiments were designed to evaluate the possibility of simplifying superovulatory treatments in Corriedale ewes with use of ovine FSH (oFSH). Ewes received intravaginal progestogen sponges for 14 days. In Experiment 1, several simplified schedules were tested. Ewes were treated with 176 NIH-FSH-S1 units' oFSH given as a single injection in saline, along with 500 IU eCG 48 h before sponge removal (Group A1), in four equal doses (B1), or given as a single injection in a polyvinylpyrrolidone vehicle (C1) 24 h before sponge removal. In Experiment 2, the simplified protocol that exhibited the most desirable results in Experiment 1 (A2) was compared with the same protocol, but using less oFSH (132 units) (B2) and with the most conventional protocol (176 units of oFSH in eight decreasing doses; C2). Estrus was detected and ewes were naturally mated. The ovarian response and embryo production were assessed on Day 6 after estrus. LH was measured at 6h intervals from pessary withdrawal. The onset of estrus and the pre-ovulatory LH surge were advanced (P<0.05) in ewes treated with FSH and eCG. In Experiment 1, protocol A1 produced a greater percentage of superovulated ewes compared to C1 (100.0 compared with 58.3%; P<0.05), increased ovulation rate (13.8 corpora lutea compared with 6.2 and 4.7 for B1 and C1, respectively; P<0.05), and tended to increase the number of transferable embryos compared to B1 (P=0.08). In Experiment 2, percentages of superovulated ewes and ovulation rates were similar among groups; however, Group A2 tended to have more large follicles (P=0.07) than C2. The number of transferable embryos was similar among the three treatments. In conclusion, the reduced-dose oFSH given once along with eCG is the most appropriate superovulatory treatment because it combines simplicity and a lesser dose of gonadotropin, which also implies a reduction in cost, without reducing embryo production.     

The use of FSH and GnRH as alternative compounds to PMSG for springtime breeding of ewes

During early springtime, ewes were treated with a single injection of PMSG (500 IU) administered at the time of progesterone sponge withdrawal (Group I) or four, twice daily injections of FSH (2 mg each) administered from twelve hours before, to 24 hours after sponge withdrawal (Group II). One hundred mug of GnRH was administered 36 hours after sponge withdrawal in Group II. The two groups were compared with respect to estrous display, conception rate and other reproductive parameters. There were no significant differences (p>.05) between the two treatment group in any of the reproductive parameters measured. The occurrence of estrus during the first 96 hours after synchronization was low (X = 45% of all treated ewes). Conception of all treated ewes during this estrous period was also low (X = 32% of all treated ewes). The potential use of FSH and GnRH in estrous synchronization regimes was discussed. Possible reasons for the poor estrous and conception rates in present experiment were also considered.     

Effects of FSH commercial preparation and follicular status on follicular growth and superovulatory response in Spanish Merino ewes

Ovarian follicular development was characterized in 24 Spanish Merino ewes to study effects of the follicular status and the FSH commercial product used on follicular growth and subsequent superovulatory response. Estrus was synchronized using 40 mg fluorogestone acetate sponges. The superovulatory treatment consisted in 2 daily i.m. injections of FSH from 48 h before to 12 h after sponge removal. Sheep were assigned randomly to 2 groups treated with 6 decreasing doses (4, 4, 3, 3, 2, 2 mg) of FSH-P or with 6 doses of 1.25 mL of OVAGEN. Growth and regression of all follicles > or = 2 mm were observed by transrectal ultrasonography, and recorded daily from Day 6 before sponge insertion to the first FSH injection, and then twice daily until estrus was detected with vasectomized rams. Differences were detected in follicular development from the first FSH injection to detection of estrus (-48 to 36 h from sponge removal) between groups. Administration of FSH-P increased the appearance of new follicles with respect to OVAGEN (6.3 +/- 0.7 vs 4.8 +/- 0.4; P < 0.05), and the mean number of medium (4 to 5 mm) follicles (8.9 +/- 1.2 vs 6.6 +/- 0.9; P < 0.05). However, the mean number of follicles that regressed in size after sponge removal (5.9 +/- 0.4 vs 3.3 +/- 0.4) and the number of preovulatory sized follicles that did not ovulate (60 vs 42.4%) were also higher in FSH-P treated ewes (P < 0.05). So, finally, there were no differences in ovulation rate, as determined by laparoscopy on Day 7 after sponge removal, between ewes treated with FSH-P or OVAGEN (6.3 +/- 1.9 vs 7.0 +/- 1.7 CL). In all the ewes, the ovulatory response was related (P < 0.05) both to the number of small follicles (2 to 3 mm in diameter) present in the ovaries at the start of treatment with exogenous FSH and to the number of follicles that reached > or = 4 mm in size at estrus, despite differences in the pattern of follicular development when using different commercial products.     

A controlled internal drug-release dispenser containing progesterone for control of the estrous cycle of ewes

Experiments were conducted to evaluate a controlled internal drug-release (CIDR) dispenser containing progesterone to control the estrous cycle of ewes. After insertion of CIDR dispensers into the vaginae of ovariectomized ewes (Experiment 1; n = 11), the mean plasma progesterone rose from 0.74 ± 0.2 ng/ml to a peak of 5.5 ± 1.0 ng/ml within 2 h and then declined to 3.0 ± 0.5 ng/ml by 48 h. This was followed by a more gradual decline to 1.7 ± 0.3 ng/ml at the time of removal 12 or 14 d later. Following removal, the levels declined to baseline within 4 h. In Experiment 2, a 12- or 14-d treatment with CIDR dispensers was initiated in ewes 2, 9 and 16 d after synchronization of the estrous cycle with fluorogestone acetate (FGA)-impregnated intravaginal sponges. An intramuscular (i.m.) injection of 500 IU pregnant mare serum gonadotropin (PMSG) was given at the time of removal of the FGA sponge or CIDR dispenser. Based on plasma progesterone profiles, CIDR dispensers inserted 9 or 16 d after FGA sponge removal delayed the onset of a new estrous cycle until they were withdrawn. Following withdrawal, ovulation was effectively synchronized in all treatment groups and accompanied by development of functionally active corpora lutea with a normal lifespan. In Experiment 3, comparison of the mating response of ewes after treatment with CIDR dispensers (n = 192) or FGA sponges (n = 194) showed that 92% and 91% of the treated ewes, respectively, were marked by the ram within 72 h. Fertility and litter size of ewes bred at the synchronized and followup estrus were similar for both treatments. These results indicate that treatment of ewes with CIDR dispensers containing progesterone maintains plasma levels of progesterone within the range found during the normal estrous cycle. The CIDR dispenser is effective in synchronizing the estrous cycle of adult ewes and offers a promising alternative to the FGA-impregnated intravaginal sponge.     

Artificial insemination of ewes with frozen-thawed semen at a synchronized oestrus. 1. Effect of time of onset of oestrus, ovulation and insemination on fertility

In three experiments, the onset of oestrus, time of ovulation and lambing after intrauterine insemination with frozen-thawed semen were examined following synchronisation of oestrus using intravaginal progestagen-impregnated sponges (inserted for 12 days) and an injection of PMSG at sponge removal.

The number (and percentage) of ewes detected in oestrus 12, 24, 36, 48, 60 and 72 h after sponge removal was 1 (0.3), 2 (0.6), 17 (5.2), 120 (36.7), 65 (20.0) and 10 (3.1) respectively. One hundred and twelve ewes (34.3%) remained unmarked. Egg fertilisation rates were not different between ewes irrespective of time of onset of oestrus or whether or not ewes were marked.

The median time of ovulation with respect to sponge removal (with 95% fiducial limits) for ewes joined with vasectomised rams (10:1) at spronge removal (teased ewes) was 55.8 h (54.61–57.09) and for unteased ewes 59.7 h (58.27–61.12).

In the third experiment, a total of 394 ewes were inseminated by laparoscopy with frozen-thawed semen. The percentage of ewes lambing and lambs born per ewe inseminated, and number of lambs born per ewe lambing for inseminations 48, 60, 72 and 78 h after sponge removal were 45.9, 57.7 and 1.25; 55.1, 72.0 and 1.31; 57.4, 80.9 and 1.41; and 39.3, 60.7 and 1.54, and for 59 control ewes receiving fresh semen by cervical insemination 47.5, 69.5 and 1.46 respectively. The lambing data after insemination with frozen semen was not different to that of the controls. The percentage of ewes lambing and lambs born per ewe inseminated increased with time of insemination at 48, 60 and 72 h (linear, P < 0.01) but was lower for inseminations at 78 h after sponge removal. Number of lambs born per ewe lambing increased with time of insemination after sponge removal (linear, P < 0.05).